ReviewFrontiers in microbiology2026
Targeting the gut-brain axis: novel strategies for disease intervention from mechanisms to clinical practice.
Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The gut-brain axis is a bidirectional communication network linking the gastrointestinal tract and the central nervous system (CNS), in which the gut microbiota and its metabolites have emerged as important modulators. Alterations in the gut microbiota have been reported in a range of neurological, psychiatric, and metabolic disorders, but their underlying mechanisms and causal relevance in humans are still unclear. This review examines the major neural, endocrine, immune, and metabolic pathways involved in microbiota-gut-brain communication and discusses how their disruption may affect neurotransmitter signaling, inflammation, barrier function, and host metabolism. We also review current intervention strategies, including microbiota modulation, dietary and metabolic approaches, neural and immunomodulatory interventions, and behavioral and traditional Chinese medicine (TCM) approaches. Particular attention is given to the strength of the available evidence, its clinical relevance, and the limitations and safety considerations that need to be addressed before gut-brain-axis-based strategies can be more widely applied.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.